0
Skip to Content
The TruScreen Device
HPV Test Kits
Clinical Performance
Development History
Eliminating Cervical Cancer
Markets
Our People
Investors
Contact
News
Open Menu
Close Menu
The TruScreen Device
HPV Test Kits
Clinical Performance
Development History
Eliminating Cervical Cancer
Markets
Our People
Investors
Contact
News
Open Menu
Close Menu
The TruScreen Device
HPV Test Kits
Clinical Performance
Development History
Eliminating Cervical Cancer
Markets
Our People
Investors
Contact
News
Opening of Public Offer and Publication of Research Report
26 Nov
Written By
NZX - OFFER
Previous
Previous
Public Offer Acceptance Reaches Target NZ$1.5 Million
Next
Next
Application for Dual Listing of TruScreen's Shares on the ASX